Corvus Pharmaceuticals, Inc. (CRVS) vs Geron Corporation (GERN)
- Corvus Pharmaceuticals, Inc. CRVS 9.52 −3.35%
- Geron Corporation GERN 1.17 −4.88%
Corvus Pharmaceuticals, Inc. and Geron Corporation are both Biotechnology companies. Corvus Pharmaceuticals, Inc. and Geron Corporation are of similar size ($828.6M and $790.2M). Corvus Pharmaceuticals, Inc. has the higher net margin (0.00% vs −33.1%) and the lower return on invested capital (−352.5% vs −89.9%). Across the 14 metrics below, Corvus Pharmaceuticals, Inc. leads on 10 and Geron Corporation on 4.
Valuation
Profitability
| Metric | CRVS | GERN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 93.51% | 65.16% |
| Operating margin | 0.00% | (25.31%) | 0.00% |
| Net margin | 0.00% | (33.05%) | 0.00% |
| Free cash flow margin | 0.00% | (56.10%) | 0.00% |
| Return on equity | (18.98%) | (28.28%) | (56.36%) |
| Return on assets | (17.64%) | (12.59%) | (48.04%) |
| Return on invested capital | (352.49%) | (89.85%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack